For decades, inspection readiness often meant preparing for a scheduled audit.
But food safety oversight is evolving.
Earlier this summer, the FDA’s acting deputy commissioner for human foods announced a proposed new regulatory model that relies more heavily on AI-enabled risk-based targeting and greater data sharing with and support from states. Facilities with strong compliance histories may experience different oversight patterns than organizations that struggle to demonstrate control over food-safety risks.
That's good news for food and beverage manufacturers who already have a great audit track record, but what about those who don't? Or, more commonly, those that have passed inspections only after scrambling to assemble paper records, spreadsheets, and disconnected data?
Adding to the challenge is that manufacturers still have limited visibility into how FDA's emerging risk-based models work. FDA has discussed using AI and data-driven approaches to prioritize oversight activities, but has not publicly detailed all of the inputs, thresholds, or factors that may influence risk assessments.
That uncertainty makes one thing clear: organizations cannot rely on a known checklist for FDA inspection readiness. Manufacturers may not know exactly what regulators are looking for, but they can ensure they have complete, accessible records that demonstrate food-safety controls are working every day. In short, the question for manufacturers is no longer "Can we pass the inspection?" but rather "Can we prove control every day?"
Why inspections are becoming more data-driven
The recent run of major recalls makes the announcement feel especially timely. It also underscores why FDA has been exploring more targeted, data-driven oversight models since at least 2019: regulators are under pressure to focus limited inspection resources where risk is highest.
But this isn’t a panicked emergency measure by any means. In spring 2026, the FDA concluded a pilot program of one-day “inspectional assessments” for facilities that artificial intelligence (AI) has identified as lower-risk. At the conclusion of the pilot, most one-day inspections resulted in “No Action Indicated” (NAI) outcomes. Some industry commentators have suggested that may confirm either the quality of AI-based risk stratification or that, well, low-risk facilities really are low-risk.
Under the pilot, FDA did not tell facilities up front that an inspection was intended to last one day. A facility might only know after the fact, and if investigators found significant observations, FDA could extend the inspection.
This pilot is extending through 2026 and does not currently replace standard FDA inspections, nor does it replace other alternative tools like remote records review. It simply gives FDA another inspection option for facilities with strong compliance histories and lower-risk operations. If investigators find significant observations, those findings can still be documented on a Form 483, and higher-risk or more complex facilities will continue to receive full inspections. FDA’s launch of Elsa, an internal generative AI tool for agency staff, points in the same direction: faster access to information, better use of limited resources, and more data-enabled regulatory workflows.
The one-day pilot is only one piece of the shift. FDA’s BRIDGE initiative points to another: a more coordinated inspection model that relies more heavily on state partners for routine oversight, while federal resources focus on higher-risk, more complex, foreign, or non-routine inspections. As its own announcement notes, this move is intended to help reduce the “duplication, gaps in inspection coverage, and inefficient use of limited resources” caused by the parallel nature of inspections and related data across federal and state programs. While a clear efficiency win for the FDA, it may hold even more impact for manufacturers than the flashier AI-aided inspection announcement.
What this new inspection model means for food and beverage manufacturers
When a regulatory body announces a new way of doing things, even the most detailed notice can lack a plain-language explanation of what those changes will mean for manufacturers. Here's our breakdown:
BRIDGE may make oversight more coordinated for regulators, but less centralized for manufacturers.
If state partners take on more routine inspections while FDA focuses federal resources on higher-risk, foreign, complex, or non-routine cases, manufacturers may interact with a broader mix of oversight bodies. The food-safety expectations may not change, but the inspection pathway could. Put another way, the person asking for records may be a state inspector, a federal FDA investigator, or part of a more coordinated inspection network, depending on the facility, issue, location, or risk signal.
BRIDGE is designed to reduce gaps, duplication, and inefficiencies between federal and state inspection programs, including how inspection-related information is shared and used. For food and beverage manufacturers, that means oversight may feel less like separate state and federal tracks and more like a connected inspection network. The food-safety expectations may not change, but the visibility of your records could. Maintenance histories, corrective actions, and audit trails should tell a consistent story whether the request comes from a state program, FDA, or a coordinated inspection process.
No (current) need to align to a new, invisible standard
The announcement of an “AI-enabled risk prioritization” may inspire panic over a new prioritization standard you need to meet, ASAP. However, the truth is, we just don’t have the details to confirm what those standards might be. The FDA has not publicly detailed the AI models, inputs, or risk-scoring thresholds it plans on using, and you can’t optimize your operations for a scoring system you can’t see.
So while there’s no need to panic over a new standard that hasn’t yet been communicated, there is a clear need to strengthen the evidence you already control.
A greater need for evidence at the ready
If oversight becomes more targeted and more distributed, documentation becomes even more important for compliance. Teams may need to respond to questions from different authorities, not just one familiar inspection pathway.
That means records need to be complete, current, and easy to access. Maintenance histories, sanitation follow-through, equipment records, corrective actions, calibration records, and audit trails all become part of the evidence that shows how food-safety risks are being identified, addressed, and tracked.
For food and beverage manufacturers, maintenance plays a direct role in food safety and regulatory readiness. That evidence often connects directly to the systems regulators already care about: HACCP plans, preventive controls, sanitation standard operating procedures, environmental monitoring, allergen controls, and corrective and preventive actions. If a mixer, filler, refrigeration unit, conveyor, or critical control point goes out of spec, teams need to show not only that the issue was found, but that it was documented, assigned, resolved, and verified.
This is where a connected maintenance management system can make a real difference. Instead of chasing down paper work orders, spreadsheet updates, sanitation checks, and disconnected maintenance records when an inspection begins, teams can use eMaint to centralize maintenance activity, standardize corrective actions, and keep a clearer audit trail of what happened, when it happened, and who completed the work.
The goal is not to look low-risk on paper while working to a ‘new’ FDA checklist. The goal is to show, quickly and clearly, that your operation is under control, no matter who is asking.
Need help assessing whether your maintenance documentation can support inspection readiness across different regulatory contexts? Schedule a maintenance maturity discussion to see where your operations stand.
